AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. FIX
8. BE
9. AXP
10. NDAQ

Go back to AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

Amgen (AMGN) Q4 earnings and revenue beat estimates

February 6, 2024 4:14 PM EST

Amgen (NASDAQ: AMGN) posted better-than-expected fourth-quarter earnings and revenue.

The biopharma company reported Q4 earnings per share (EPS) of $4.71, topping the consensus projection of $4.59. It generated $8.2 billion in revenue during the quarter, up 20% year-over-year, and above the estimated $8.12 billion.

Product sales brought in... More

Amgen (AMGN) Tops Q4 EPS by 12c, Offers Guidance

February 6, 2024 4:03 PM EST

Amgen (NASDAQ: AMGN) reported Q4 EPS of $4.71, $0.12 better than the analyst estimate of $4.59. Revenue for the quarter came in at $8.2 billion versus the consensus estimate of $8.12 billion.

GUIDANCE:

Amgen sees FY2024 EPS of $18.90-$20.30, versus the consensus of $19.83. Amgen sees... More